Announced Tue, 23 Dec · 16:15 IST

The Board of Directors in its meeting held on 23.12.2025 has inter-alia approved the following: a. Increase in Authorised Capital b. Further issue of Equity Capital on Preferential allotment ....

Strategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Raaj Medisafe India Ltd, at its meeting on December 23, 2025, approved expanding its manufacturing capacity for packing materials and hygiene products at a cost of Rs. 15 crore. It also approved acquiring the business of Goa-based Fabrizo Industries Pvt. Ltd., including plant and machinery, for Rs. 28 crore. To fund these moves, the Board cleared a further issue of equity shares worth Rs. 1,801.25 lakhs (including premium) via preferential allotment or private placement to select non-promoter investors. The Authorised Capital will be increased from Rs. 1,500 lakhs to Rs. 1,800 lakhs, subject to shareholder approval. An Extra-ordinary General Meeting has been scheduled for January 20, 2026 to seek these approvals.

Likely market impact

Existing shareholders may see dilution as new equity is being issued to non-promoter investors, though the funds will support growth via capacity expansion and acquisition. The acquisition of Fabrizo Industries could add to the company's product portfolio, but investors should watch for the detailed rationale and valuation at the EGM.